Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Rare Pediatric Voucher Program Faces Tight Deadline For Reauthorization
Sep 04 2024
•
By
Sue Sutter
The sun will start setting on the FDA's rare pediatric disease PRV program on 30 September. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Rare Diseases
More from Pink Sheet